FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine October 6, 2020
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference September 11, 2020
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine August 20, 2020
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies July 22, 2020
